Sfoglia per AUTORE
D'AVOLIO A
Collezione ASL Città di Torino

  

Items : 230

UHPLC-MS/MS method for the simultaneous quantification of five calcium channel antagonists' drugs in human plasma. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2025 Mar;184:117873. doi: 10.1016/j.biopha.2025.117873. Epub 2025 Feb 5.
2025
ASL Città di Torino

Rabbia F; Cantù M; De Rosa FG; Fasano C; Ponsa L; Pappaccogli M; Menegatti G; Antonucci M; Manca A; Cusato J; De Nicolò A; Billi M; Palermiti A; Veglio F; D'Avolio A;

'Real-life' approach to applying PK/PD principles in infectious diseases clinical practice without access to prompt TDM. in Expert review of anti-infective therapy / Expert Rev Anti Infect Ther. 2025 Jan 2:1-16. doi: 10.1080/14787210.2024.2448727.
2025
ASL Città di Torino

Geremia N; Di Bella S; Lovecchio A; Angelini J; D'Avolio A; Luzzati R; Mearelli F; Principe L; Oliva A;

How Antiretroviral Drug Concentrations Could Be Affected by Oxidative Stress, Physical Capacities and Genetics: A Focus on Dolutegravir Treated Male PLWH. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2025 Jan 13;14(1):82. doi: 10.3390/antiox14010082.
2025
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Lupo C; Rainoldi A; Di Perri G; Bonora S; Trevisan G; Cuomo S; Tettoni MC; Chiara F; Mula J; Antonucci M; Bianco G; Accardo G; Palermiti A; Ferrara M; Manca A; Mulasso A; Cusato J;

Clinical Pharmacology of Bulevirtide: Focus on Known and Potential Drug-Drug Interactions. in Pharmaceutics / Pharmaceutics. 2025 Feb 14;17(2):250. doi: 10.3390/pharmaceutics17020250.
2025
ASL Città di Torino

Billi M; Soloperto S; Bonora S; D'Avolio A; De Nicolò A;

Rifampin-like Red-brown Bronchial Secretions Staining in a Patient Treated with Cefiderocol. in The new microbiologica / New Microbiol. 2024 Nov;47(3):295-297.
2024
ASL Città di Torino

Lupia T; Casarotto M; D'Avolio A; Mula J; Curtoni A; Corcione S; De Rosa FG;

Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 May 2;68(5):e0017524. doi: 10.1128/aac.00175-24. Epub 2024 Mar 27.
2024
ASL Città di Torino

Cossu MV; D'Avolio A; Gervasoni C; Giacomelli A; Cattaneo D; Moschese D;

Rilpivirine and cabotegravir trough concentrations in people with HIV on long-term treatment with long-acting injectable antiretrovirals. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2024 May 2;79(5):1126-1132. doi: 10.1093/jac/dkae080.
2024
ASL Città di Torino

Cossu MV; Cattaneo D; Moschese D; Giacomelli A; Soloperto S; D'Avolio A; Antinori S; Gori A; Rizzardini G; Gervasoni C;

Pharmacogenetics of tenofovir drug transporters in the context of HBV: Is there an impact? in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116678. doi: 10.1016/j.biopha.2024.116678. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

Boglione L; D'Avolio A; De Nicolò A; Lupia T; Stroffolini G; Antonucci M; Chiara F; Mula J; Palermiti A; Manca A; Cusato J;

Cannabinoid levels description in a cohort of patients with chronic and neuropathic pain treated with Cannabis decoction: A possible role of TDM. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2024 Jun;175:116686. doi: 10.1016/j.biopha.2024.116686. Epub 2024 May 6.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Luxardo N; Imperiale D; De Cori D; Vischia F; Nicolò A; Palermiti A; Antonucci M; Billi M; Valz C; Chiara F; Mula J; Cusato J; Manca A;

Host single nucleotide polymorphisms and biomarkers of neuronal damage and inflammation in people living with HIV. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Jun;63(6):107137. doi: 10.1016/j.ijantimicag.2024.107137. Epub 2024 Ma
2024
ASL Città di Torino

D'Avolio A; Di Perri G; Bonora S; Trunfio M; Antonucci M; Marinaro L; Avataneo V; Mula J; Palermiti A; Manca A; Cusato J; Calcagno A;

Low azithromycin maximal concentrations in patients concomitantly taking rifampicin: time to move away from rifampicin in the treatment of non-tuberculous mycobacteria? in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2024 Jul 9;68(7):e0023424. doi: 10.1128/aac.00234-24. Epub 2024 May 24.
2024
ASL Città di Torino

D'Avolio A; Marinaro L; Alladio F; Ponzetta L; Cat Genova E; Quaranta M; Stroffolini G; Venuti F; de Nicolò A; Gaviraghi A; Calcagno A;

Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn's Disease. in Biomedicines / Biomedicines. 2024 Jan 30;12(2):320. doi: 10.3390/biomedicines12020320.
2024
ASL Città di Torino
AOU Città della Salute di Torino

Ribaldone DG; D'Avolio A; Saracco GM; Armandi A; Caviglia GP; Vernero M; Manca A; Palermiti A; Antonucci M; Cafasso C; Cusato J;

Pharmacokinetics of tecovirimat in subjects with Mpox. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2024 Feb;63(2):107068. doi: 10.1016/j.ijantimicag.2023.107068. Epub 2023 De
2024
ASL Città di Torino

Tempestilli M; Mondi A; D'Avolio A; Forini O; Pinnetti C; Mazzotta V; Gagliardini R; Beccacece A; De Nicolò A; Faccendini P; Cimini E; Maggi F; Girardi E; Nicastri E; Boffito M; Vaia F; Antinori A;

Development and Validation of a UHPLC-MS/MS Method for the Simultaneous Quantification of Candesartan and Bisoprolol Together with Other 16 Antihypertensive Drugs in Plasma Samples. in Journal of medicinal chemistry / J Med Chem. 2024 Dec 26;67(24):22124-22133. doi: 10.1021/acs.jmedchem.4c02045. Epub 2024 Dec 4.
2024
ASL Città di Torino

Veglio F; Rabbia F; De Rosa FG; Fasano C; Ponsa L; Pappaccogli M; Carta A; Cusato J; Billi M; Mula J; Antonucci M; Manca A; De Nicolò A; Palermiti A; D'Avolio A;

Therapeutic Drug Monitoring as a Tool for the Clinical Outcome Prediction in Vedolizumab-Treated Patients: An Italian Pilot Study. in Biomedicines / Biomedicines. 2024 Apr 9;12(4):824. doi: 10.3390/biomedicines12040824.
2024
ASL Città di Torino

Caviglia GP; D'Avolio A; Fornaroli G; Bottari A; Costa F; Ceccarelli L; Saracco GM; Palermiti A; Antonucci M; Manca A; Falzone MH; Ribaldone DG; Cusato J; Bertani L;

Studying the Changes in Physical Functioning and Oxidative Stress-Related Molecules in People Living with HIV after Switching from Triple to Dual Therapy. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2024 Apr 26;13(5):518. doi: 10.3390/antiox13050518.
2024
ASL Città di Torino
AOU San Luigi di Orbassano

Rainoldi A; D'Avolio A; Di Perri G; Lupo C; Bonora S; Trevisan G; Cuomo S; Maddalone MG; Tettoni MC; Mula J; Chiara F; Bianco G; Accardo G; Palermiti A; Antonucci M; Ferrara M; Manca A; Mulasso A; Cusato J;

Long-term oritavancin therapy for shoulder prosthetic joint infection: A case guided by therapeutic drug monitoring (TDM). in IDCases / IDCases. 2024 Oct 31;38:e02105. doi: 10.1016/j.idcr.2024.e02105. eCollection 2024.
2024
ASL Città di Torino

Buonomo AR; Cattaneo L; Viceconte G; Calabria F; Di Troia G; Di Fusco A; Mula J; Cozzolino A; Ametrano L; D'Avolio A; Gentile I;

2023
ASL Città di Torino

Manca A; Palermiti A; Mula J; Cusato J; Maiese D; Simiele M; De Nicolò A; D'Avolio A;

Vitamin D impact in affecting clozapine plasma exposure: A potential contribution of seasonality. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Sep;165:115103. doi: 10.1016/j.biopha.2023.115103. Epub 2023 Jul 4.
2023
ASL Città di Torino

Vivo ED; Antonucci M; Nicolò A; Maiese D; Emanuelli G; Venturello S; Cori D; Vischia F; Palermiti A; Mula J; Manca A; Cusato J; D'Avolio A;

Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2023 Nov 6;78(11):2776-2778. doi: 10.1093/jac/dkad277.
2023
ASL Città di Torino

Funiciello E; Mula J; Mignone F; Silvestro E; Ragazzi P; Pilloni G; Costa C; D'Avolio A; Garazzino S;

COVID-19: Focusing on the Link between Inflammation, Vitamin D, MAPK Pathway and Oxidative Stress Genetics. in Antioxidants (Basel, Switzerland) / Antioxidants (Basel). 2023 May 20;12(5):1133. doi: 10.3390/antiox12051133.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Bonora S; Di Perri G; Ferrara M; De Vivo ED; Maiese D; Antonucci M; Chiara F; Costanzo M; Mula J; Manca A; Palermiti A; Cusato J;

COVID-19: A Possible Contribution of the MAPK Pathway. in Biomedicines / Biomedicines. 2023 May 16;11(5):1459. doi: 10.3390/biomedicines11051459.
2023
ASL Città di Torino

De Rosa FG; Di Perri G; Ferrara M; Ianniello A; De Vivo ED; Chiara F; Corcione S; Trunfio M; Antonucci M; Costanzo M; Mula J; Palermiti A; Manca A; Cusato J; D'Avolio A; Calcagno A;

A Novel UHPLC-MS/MS Method for the Quantification of Seven Opioids in Different Human Tissues. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2023 Jun 19;16(6):903. doi: 10.3390/ph16060903.
2023
ASL Città di Torino

Manca A; De Nicolò A; De Vivo ED; Ferrara M; Oh S; Khalili S; Higgins N; Deiss RG; Bonora S; Cusato J; Palermiti A; Mula J; Gianella S; D'Avolio A;

2023
ASL Città di Torino

Bonora S; Cinnirella G; D'Avolio A; Marchiaro C; Catellani E; Romano F; Quaranta M; Ranzani FA; Di Vincenzo A; Longo BM; Stroffolini G; De Nicolò A; Gaviraghi A; Venuti F; Calcagno A;

Analytical validation of a novel UHPLC-MS/MS method for 19 antibiotics quantification in plasma: Implementation in a LC-MS/MS Kit. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2023 Jul;163:114790. doi: 10.1016/j.biopha.2023.114790. Epub 2023 Apr 29.
2023
ASL Città di Torino
AOU San Luigi di Orbassano

De Nicolò A; De Rosa FG; Di Perri G; Simiele M; Cusato J; Maiese D; Palermiti A; Manca A; Chiara F; Mula J; D'Avolio A;

Antiretroviral Levels in the Cerebrospinal Fluid: The Effect of Inflammation and Genetic Variants. in Diagnostics (Basel, Switzerland) / Diagnostics (Basel). 2023 Jan 12;13(2):295. doi: 10.3390/diagnostics13020295.
2023
ASL Città di Torino

D'Avolio A; Bonora S; Mula J; Di Perri G; Manca A; Palermiti A; Marinaro L; Trunfio M; Antonucci M; Avataneo V; Cusato J; Calcagno A;

A combined role for low vitamin D and low albumin circulating levels as strong predictors of worse outcome in COVID-19 patients. in Irish journal of medical science / Ir J Med Sci. 2023 Feb;192(1):423-430. doi: 10.1007/s11845-022-02952-9. Epub 2022 Feb 19.
2023
ASL Città di Torino

di Masi A; Cusato J; Koncan R; Di Bella S; Zerbato V; Segat L; Sanson G; De Nicolò A; Palermo A; Caironi P; D'Agaro P; Luzzati R; D'Avolio A;

Pharmacokinetics and pharmacogenetics of high-dosage tedizolid for disseminated nocardiosis in a lung transplant patient. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2023 Dec 1;78(12):3003-3004. doi: 10.1093/jac/dkad299.
2023
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Mangiapia M; Cusato J; Mornese Pinna S; Scabini S; De Nicolò A; Corcione S; Vita D; De Rosa FG;

Ceftobiprole and daptomycin concentrations in valve tissue in a patient with mitralic native valve endocarditis. in Journal of chemotherapy (Florence, Italy) / J Chemother. 2022 Oct;34(6):416-418. doi: 10.1080/1120009X.2022.2068850. Epub 2022 Apr 28.
2022
ASL Città di Torino

Boni S; Antonucci M; Manca A; Nicolò A; Martinelli L; Artioli S; Pacini G; Di Perri G; D'Avolio A;

Antifungal Drug Plasma Exposures: A Possible Contribution of Vitamin D-Related Gene Variants. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 May 20;15(5):630. doi: 10.3390/ph15050630.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Calcagno A; Rosa FG; Chiara F; Di Perri G; Allegra S; De Francia S; De Nicolò A; Antonucci M; Manca A; Mula J; Palermiti A; Cusato J;

Factors Influencing the Intracellular Concentrations of the Sofosbuvir Metabolite GS-331007 (in PBMCs) at 30 Days of Therapy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2022 Mar 15;15(3):355. doi: 10.3390/ph15030355.
2022
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Caviglia GP; Mornese Pinna S; Ciancio A; Troshina G; Smedile A; Antonucci M; Avataneo V; Palermiti A; Mula J; Manca A; Cariti G; Cantù M; Saracco GM; Di Perri G; D'Avolio A;

A description of Cannabinoid levels in Cannabis oil by high-performance liquid chromatography-mass spectrometry in a reference laboratory of North-Italy. in Phytomedicine : international journal of phytotherapy and phytopharmacology / Phytomedicine. 2022 Jul 20;102:154218. doi: 10.1016/j.phymed.2022.154218. Epub 2022 May 28.
2022
ASL Città di Torino

Manca A; Palermiti A; Mula J; De Vivo ED; Zeaiter S; Simiele M; De Nicolò A; Cantù M; Cusato J; D'Avolio A;

2022
ASL Città di Torino

Avataneo V; Palermiti A; De Nicolò A; Cusato J; Giussani G; Calcagno A; D'Avolio A;

Pharmacokinetic of Cefiderocol in Critically Ill Patients Receiving Renal Replacement Therapy: A Case Series. in Antibiotics (Basel, Switzerland) / Antibiotics (Basel). 2022 Dec 16;11(12):1830. doi: 10.3390/antibiotics11121830.
2022
ASL Asti
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; Di Perri G; D'Avolio A; Mula J; Lupia T; Vita D; De Benedetto I; Scabini S; De Nicolò A; Montrucchio G; Mornese Pinna S; Corcione S;

A new UHPLC-MS/MS method for cannabinoids determination in human plasma: A clinical tool for therapeutic drug monitoring. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2022 Dec;156:113899. doi: 10.1016/j.biopha.2022.113899. Epub 2022 Oct 21.
2022
ASL Città di Torino
AOU San Luigi di Orbassano

De Filippis G; Vischia F; De Cori D; Cusato J; D'Avolio A; De Nicolò A; Imperiale D; Maiese D; Mula J; Zeaiter S; Palermiti A; Manca A; Chiara F;

Pregnancy and COVID-19: The Possible Contribution of Vitamin D. in Nutrients / Nutrients. 2022 Aug 10;14(16):3275. doi: 10.3390/nu14163275.
2022
ASL Città di Torino
AOU Città della Salute di Torino

Cusato J; D'Avolio A; Benedetto C; Corcione S; De Rosa FG; Carosso AR; Borella F; Ianniello A; De Vivo ED; Costanzo M; Antonucci M; Palermiti A; Cosma S; Manca A;

Indirect hyperbilirubinemia and jaundice during chronic hepatitis C in an HIV-infected patient treated with glecaprevir/pibrentasvir (GLE/PIB) and antiretroviral therapy (ART). The first reported case in Italy. in Journal of preventive medicine and hygiene / J Prev Med Hyg. 2022 Oct 27;63(3):E420-E423. doi: 10.15167/2421-4248/jpmh2022.63.3.2137. eCollection
2022
ASL Città di Torino

Mastroianni A; Vangeli V; Greco S; Chidichimo L; Urso F; Mauro MV; Bonora S; DE Nicolò A; D'Avolio A;

2021
ASL Città di Torino
AOU Città della Salute di Torino

De Rosa FG; Di Perri G; Stella M; D'Avolio A; Corgiat Loia R; Romeo MR; Pensa A; Lupia T; Segala FV; Corcione S; De Nicolò A;

Seasonal Variation of Antiretroviral Drug Exposure during the Year: The Experience of 10 Years of Therapeutic Drug Monitoring. in Biomedicines / Biomedicines. 2021 Sep 12;9(9):1202. doi: 10.3390/biomedicines9091202.
2021
ASL Città di Torino

Cusato J; Mula J; Palermiti A; Manca A; Antonucci M; Avataneo V; De Vivo ED; Ianniello A; Calcagno A; Di Perri G; De Nicolò A; D'Avolio A;

2021
ASL Città di Torino

Cusato J; Tempestilli M; Calcagno A; Vergori A; Piselli P; Antonucci M; Avataneo V; Palermiti A; Notari S; Antinori A; Di Perri G; Agrati C; D'Avolio A;

Vitamin D-Related Genetics as Predictive Biomarker of Clinical Remission in Adalimumab-Treated Patients Affected by Crohn's Disease: A Pilot Study. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Nov 27;14(12):1230. doi: 10.3390/ph14121230.
2021
ASL Città di Torino

Ribaldone DG; Zanzi F; Astegiano M; Ceccarelli L; Costa F; Mula J; Massano A; Mangia M; Dibitetto S; Caviglia GP; Tomasello C; Bertani L; Antonucci M; D'Avolio A; Cusato J;

2021
ASL Città di Torino

Walimbwa SI; Kaboggoza JP; Waitt C; Byakika-Kibwika P; D'Avolio A; Lamorde M;

Pharmacokinetics of bictegravir, emtricitabine and tenofovir alafenamide in a gastrectomized patient with HIV. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2021 Nov 12;76(12):3320-3322. doi: 10.1093/jac/dkab319.
2021
ASL Città di Torino

Tempestilli M; D'Avolio A; De Nicolò A; Agrati C; Antinori A; Cicalini S;

Analysis of Cannabinoids Concentration in Cannabis Oil Galenic Preparations: Harmonization between Three Laboratories in Northern Italy. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 May 14;14(5):462. doi: 10.3390/ph14050462.
2021
ASL Città di Torino

Palermiti A; Cafaro A; Barco S; Bucchioni P; Franceschini P; Cusato J; De Nicolò A; Manca A; De Vivo ED; Russo E; Cecchi F; Pigliasco F; Lillo F; Tripodi G; D'Avolio A; Cangemi G;

2021
ASL Città di Torino

De Nicolò A; Manca A; Ianniello A; Palermiti A; Calcagno A; Ferrara M; Antonucci M; Cusato J; Avataneo V; De Vivo E; Bonora S; De Rosa FG; Di Perri G; D'Avolio A;

Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses? in International journal of antimicrobial agents / Int J Antimicrob Agents. 2021 Mar;57(3):106297. doi: 10.1016/j.ijantimicag.2021.106297. Epub 2021 Fe
2021
ASL Città di Torino

Bonora S; Di Perri G; D'Avolio A; Piccioni P; De Nicolò A; Barco A; Rossi G; Costa C; Pirriatore V; Antonucci M; Motta I; Borgogno E; Trentalange A; Calcagno A;

Trend of 25-hydroxycholesterol and 27-hydroxycholesterol plasma levels in patients affected by active chronic hepatitis B virus infection and inactive carriers. in The Journal of steroid biochemistry and molecular biology / J Steroid Biochem Mol Biol. 2021 Jun;210:105854. doi: 10.1016/j.jsbmb.2021.105854. Epub 2021 Feb 22.
2021
ASL Città di Torino
AOU San Luigi di Orbassano

Poli G; Di Perri G; Lembo D; Biasi F; D'Avolio A; Cusato J; Civra A; Boglione L; Caccia C; Leoni V;

2021
ASL Città di Torino
AOU Città della Salute di Torino

Romagnoli R; Canaparo R; Tandoi F; Catalano S; Serpe L; Dell'Olio D; D'Avolio A; Antonucci M; Pizzol A; De Nicolò A; Pinon M; Calvo PL;

Low Tenofovir Plasma Exposure in HIV Oral Pre-exposure Prophylaxis Recipients with Gastrointestinal Disorders. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2021 Jan 1;65(1):e01902-20. doi: 10.1128/AAC.01902-20. Epub 2020 Oct 26
2021
ASL Città di Torino

Calcagno A; Dal Conte I; Cattaneo D; Testi R; Mistrangelo M; Gervasoni C; de Nicolò A; Bonora S; D'Avolio A; Di Perri G;

Population Pharmacokinetic and Pharmacogenetic Analysis of Mitotane in Patients with Adrenocortical Carcinoma: Towards Individualized Dosing. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):89-102. doi: 10.1007/s40262-020-00913-y.
2021
ASL Città di Torino

Yin A; Ettaieb MHT; Swen JJ; van Deun L; Kerkhofs TMA; van der Straaten RJHM; Corssmit EPM; Gelderblom H; Kerstens MN; Feelders RA; Eekhoff M; Timmers HJLM; D'Avolio A; Cusato J; Guchelaar HJ; Haak HR; Moes DJAR;

Older Age is Associated with Higher Dolutegravir Exposure in Plasma and Cerebrospinal Fluid of People Living with HIV. in Clinical pharmacokinetics / Clin Pharmacokinet. 2021 Jan;60(1):103-109. doi: 10.1007/s40262-020-00916-9.
2021
ASL Città di Torino

Calcagno A; Moltó J; Borghetti A; Gervasoni C; Milesi M; Valle M; Avataneo V; Alcantarini C; Pla-Junca F; Trunfio M; D'Avolio A; Di Giambenedetto S; Cattaneo D; Di Perri G; Bonora S;

Cannabis-Based Oral Formulations for Medical Purposes: Preparation, Quality and Stability. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2021 Feb 22;14(2):171. doi: 10.3390/ph14020171.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Brusa P; De Luca A; Collino M; Ravetto Enri L; Torta R; D'Avolio A; Pignata I; Simiele M; Baratta F;

Real-life study on the pharmacokinetic of remdesivir in ICU patients admitted for severe COVID-19 pneumonia. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2021 Dec;87(12):4861-4867. doi: 10.1111/bcp.14895. Epub 2021 Jul 4.
2021
ASL Città di Torino

Corcione S; De Nicolò A; Montrucchio G; Scabini S; Avataneo V; Bonetto C; Mornese Pinna S; Cusato J; Canta F; Urbino R; Di Perri G; Brazzi L; De Rosa FG; D'Avolio A;

Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism. in The Journal of clinical endocrinology and metabolism / J Clin Endocrinol Metab. 2021 Aug 18;106(9):e3655-e3664. doi: 10.1210/clinem/dgab290.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Mulatero P; Veglio F; Bertello C; Rabbia F; D'Avolio A; Avataneo V; Rumbolo F; Mengozzi G; Burrello J; Buffolo F; Pecori A; Monticone S;

Coronavirus disease 2019 and first-trimester spontaneous abortion: a case-control study of 225 pregnant patients. in American journal of obstetrics and gynecology / Am J Obstet Gynecol. 2021 Apr;224(4):391.e1-391.e7. doi: 10.1016/j.ajog.2020.10.005. Epub 2020 Oct 8
2021
ASL Città di Torino

Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cusato J; Carosso AR; Cosma S; Benedetto C; Di Perri G; Ghisetti V; D'Avolio A; Filippini C; Bovetti M; Carosso M; Borella F; Cusato J; Carosso AR; Cosma S; Benedetto C;

Assessment of Anti-Hypertensive Drug Adherence by Serial Aldosterone-To-Renin Ratio Measurement. in Frontiers in pharmacology / Front Pharmacol. 2021 May 10;12:668843. doi: 10.3389/fphar.2021.668843. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Monticone S; Mulatero P; Rabbia F; D'Avolio A; Veglio F; Priolo G; Avataneo V; Mengozzi G; Burrello J; Losano I; Sconfienza E; Buffolo F;

A Non-Invasive Method for Detection of Antihypertensive Drugs in Biological Fluids: The Salivary Therapeutic Drug Monitoring. in Frontiers in pharmacology / Front Pharmacol. 2022 Jan 5;12:755184. doi: 10.3389/fphar.2021.755184. eCollection 2021.
2021
ASL Città di Torino
AOU Città della Salute di Torino

Veglio F; D'Avolio A; De Rosa FG; Cusato J; Pappaccogli M; Palermiti A; De Nicolò A; Rabbia F; Fanelli E; Avataneo V;

Efficacy and safety of a single switch from etanercept originator to etanercept biosimilar in a cohort of inflammatory arthritis. in Scientific reports / Sci Rep. 2020 Sep 30;10(1):16178. doi: 10.1038/s41598-020-73183-0.
2020
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Laganà A; Peroni CL; Sanna S; Priora M; Parisi S; Ditto MC; Fusaro E;

Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2020 Oct 1;75(10):2977-2980. doi: 10.1093/jac/dkaa239.
2020
ASL Città di Torino

Tempestilli M; Caputi P; Avataneo V; Notari S; Forini O; Scorzolini L; Marchioni L; Ascoli Bartoli T; Castilletti C; Lalle E; Capobianchi MR; Nicastri E; D'Avolio A; Ippolito G; Agrati C;

25-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2. in Nutrients / Nutrients. 2020 May 9;12(5):1359. doi: 10.3390/nu12051359.
2020
ASL Città di Torino

D'Avolio A; Avataneo V; Manca A; Cusato J; De Nicolò A; Lucchini R; Keller F; Cantù M;

Pharmacokinetics of meropenem in burn patients with infections caused by Gram-negative bacteria: Are we getting close to the right treatment? in Journal of global antimicrobial resistance / J Glob Antimicrob Resist. 2020 Mar;20:22-27. doi: 10.1016/j.jgar.2019.06.011. Epub 2019 Jun 14.
2020
ASL Città di Torino
AOU Città della Salute di Torino

Romeo M; Di Perri G; Stella M; De Rosa FG; Loia RC; Pensa A; Segala FV; De Nicolò A; Fatiguso G; Corcione S; D'Avolio A;

Data on the stability of darunavir/cobicistat suspension after tablet manipulation. in Data in brief / Data Brief. 2020 Apr 12;30:105552. doi: 10.1016/j.dib.2020.105552. eCollection 2020 Jun.
2020
ASL Città di Torino

Minghetti P; Tomasello C; Maximova N; Cilurzo F; D'Avolio A; Musazzi UM; De Nicolò A; Zanon D; Manca A;

Effect of Gender and Age on Voriconazole Trough Concentrations in Italian Adult Patients. in European journal of drug metabolism and pharmacokinetics / Eur J Drug Metab Pharmacokinet. 2020 Jun;45(3):405-412. doi: 10.1007/s13318-019-00603-6.
2020
ASL Città di Torino
AOU San Luigi di Orbassano

Antonucci M; D'Avolio A; Manca A; Avataneo V; Cusato J; Allegra S; De Francia S; De Nicolò A;

Impact of imipenem concentration in lung perfusate and tissue biopsy during clinical ex-vivo lung perfusion of high-risk lung donors. in Minerva anestesiologica / Minerva Anestesiol. 2020 Jun;86(6):617-626. doi: 10.23736/S0375-9393.20.13840-9. Epub 2020 Jan 27.
2020
ASL Città di Torino
AOU Città della Salute di Torino

Rinaldi M; Ranieri VM; Mascia L; Derosa FG; Brazzi L; D'avolio A; Solidoro P; Baietto L; Mazzeo A; Cappello P; Musso T; Scutera S; Costamagna A; Balzano S; Boffini M; Del Sorbo L; Fanelli V;

2020
ASL Città di Torino

Avataneo V; de Nicolò A; Cusato J; Antonucci M; Manca A; Palermiti A; Waitt C; Walimbwa S; Lamorde M; di Perri G; D'Avolio A;

Validation of a UHPLC-MS/MS Method to Quantify Twelve Antiretroviral Drugs within Peripheral Blood Mononuclear Cells from People Living with HIV. in Pharmaceuticals (Basel, Switzerland) / Pharmaceuticals (Basel). 2020 Dec 25;14(1):12. doi: 10.3390/ph14010012.
2020
ASL Città di Torino

De Nicolò A; Ianniello A; Ferrara M; Avataneo V; Cusato J; Antonucci M; De Vivo E; Waitt C; Calcagno A; Trentalange A; Muccioli G; Bonora S; Di Perri G; D'Avolio A;

Data on compounding lopinavir and ritonavir suspension for non-cooperative COVID-19 patients. in Data in brief / Data Brief. 2020 Dec;33:106445. doi: 10.1016/j.dib.2020.106445. Epub 2020 Oct 23.
2020
ASL Città di Torino

Minghetti P; Tomasello C; Clementi E; Maximova N; Cilurzo F; D'Avolio A; De Nicolò A; Manca A; Zanon D; Musazzi UM;

Therapeutic Drug Monitoring of Dalbavancin Treatment in Severe Necrotizing Fasciitis in 3 Critically Ill Patients: A Grand Round. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):165-168. doi: 10.1097/FTD.0000000000000729.
2020
ASL Città di Torino

D'Avolio A; Cattaneo D; Veronese A; Corona A; Agarossi A;

Determination of Perampanel in Dried Plasma Spots: Applicability to Therapeutic Drug Monitoring. in Therapeutic drug monitoring / Ther Drug Monit. 2020 Apr;42(2):309-314. doi: 10.1097/FTD.0000000000000680.
2020
ASL Città di Torino

Franco V; Baruffi K; Marchiselli R; Crema F; Fattore C; Romigi A; De Giorgis V; Tartara E; Elia M; D'Avolio A; Perucca E;

The effect of vitamin D pathway genes and deferasirox pharmacogenetics on liver iron in thalassaemia major patients. in The pharmacogenomics journal / Pharmacogenomics J. 2019 Oct;19(5):417-427. doi: 10.1038/s41397-019-0071-7. Epub 2019 Jan 17.
2019
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Massano D; Pirro E; Longo F; De Francia S; Cusato J; Allegra S; D'Avolio A;

2019
ASL Città di Torino
AOU Città della Salute di Torino

De Francesco A; Mengozzi G; Pazzi M; Aprile S; Massarenti P; Puccinelli MP; Casalini V; Alladio E; Manca A; D'Avolio A;

LC-MS application for therapeutic drug monitoring in alternative matrices. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2019 Mar 20;166:40-51. doi: 10.1016/j.jpba.2018.12.040. Epub 2018 Dec 29.
2019
ASL Città di Torino

Avataneo V; D'Avolio A; Cusato J; Cantù M; De Nicolò A;

Tenofovir Alafenamide and Tenofovir Disoproxil Fumarate are not transported by Concentrative Nucleoside Transporter 2. in Diagnostic microbiology and infectious disease / Diagn Microbiol Infect Dis. 2019 Jun;94(2):202-204. doi: 10.1016/j.diagmicrobio.2018.07.001. Epub 20
2019
ASL Città di Torino

Cusato J; Calcagno A; De Nicolò A; Mogyorosi K; D'Avolio A; Di Perri G; Bonora S;

Influence of Vitamin D in Advanced Non-Small Cell Lung Cancer Patients Treated with Nivolumab. in Cancers / Cancers (Basel). 2019 Jan 21;11(1):125. doi: 10.3390/cancers11010125.
2019
ASL Città di Torino

Grossi F; Ferlazzo G; Boccardo S; Dal Bello MG; Coco S; Di Perri G; Leggieri A; Rijavec E; Cossu I; Pietra G; Mingari MC; Ottonello S; Tomasello C; Carrega P; D'Avolio A; Genova C; Cusato J;

Virological Failure in HIV to Triple Therapy With Dolutegravir-Based Firstline Treatment: Rare but Possible. in Open forum infectious diseases / Open Forum Infect Dis. 2018 Dec 10;6(1):ofy332. doi: 10.1093/ofid/ofy332. eCollection 2019 Jan.
2019
ASL Città di Torino

Pena MJ; Chueca N; D'Avolio A; Zarzalejos JM; Garcia F;

Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. in Medicina (Kaunas, Lithuania) / Medicina (Kaunas). 2019 Aug 5;55(8):441. doi: 10.3390/medicina55080441.
2019
ASL Città di Torino
AOU Città della Salute di Torino

Luzza F; D'Avolio A; Perri GD; Canaparo R; Pellicano R; Riganò D; Simiele M; Agnesod D; Nicolò A; Caviglia GP; Adriani A; Ribaldone DG; Saracco GM; Astegiano M;

Daptomycin Plasma and CSF Levels in Patients with Healthcare-Associated Meningitis. in Neurocritical care / Neurocrit Care. 2019 Aug;31(1):116-124. doi: 10.1007/s12028-018-0657-y.
2019
ASL Città di Torino

Piva S; Di Paolo A; Galeotti L; Ceccherini F; Cordoni F; Signorini L; Togni T; De Nicolò A; Rasulo FA; Fagoni N; Latronico N; D'Avolio A;

2019
ASL Città di Torino

Boglione L; De Nicolò A; Di Perri G; D'Avolio A;

Development of Standard Operating Protocols for the Optimization of Cannabis-Based Formulations for Medical Purposes. in Frontiers in pharmacology / Front Pharmacol. 2019 Jun 25;10:701. doi: 10.3389/fphar.2019.00701. eCollection 2019.
2019
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Brusa P; Collino M; De Luca A; Pignata I; Ravetto Enri L; Torta R; Baratta F; Simiele M;

Rhino-Orbital-Cerebral Mucormycosis after Allogeneic Hematopoietic Stem Cell Transplantation and Isavuconazole Therapeutic Drug Monitoring during Intestinal Graft versus Host Disease. in Mediterranean journal of hematology and infectious diseases / Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019061. doi: 10.4084/MJHID.2019.061. eCollection 2
2019
ASL Città di Torino
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Cilloni D; Guerrasio A; Barbui AM; D'Avolio A; De Gobbi M; Morotti A; Monticone V; Cavallo G; Dragani M; Gned D; Andreani G; Fadda G;

Role of CYP1A1, ABCG2, CYP24A1 and VDR gene polymorphisms on the evaluation of cardiac iron overload in thalassaemia patients. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Sep;28(9):199-206. doi: 10.1097/FPC.0000000000000348.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Avataneo V; Pirro E; Massano D; De Francia S; Longo F; Cusato J; Allegra S; D'Avolio A;

A simple UHPLC-PDA method with a fast dilute-and-shot sample preparation for the quantification of canrenone and its prodrug spironolactone in human urine samples. in Journal of pharmacological and toxicological methods / J Pharmacol Toxicol Methods. 2018 Nov-Dec;94(Pt 2):29-35. doi: 10.1016/j.vascn.2018.08.003. Epub 201
2018
ASL Città di Torino
AOU Città della Salute di Torino

Di Perri G; Veglio F; Mulatero P; Favata F; Allegra S; Fatiguso G; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A; Avataneo V; De Nicolò A; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Fatiguso G; Allegra S; Favata F; Mulatero P; Veglio F; Di Perri G; D'Avolio A;

Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Nov;84(11):2535-2543. doi: 10.1111/bcp.13706. Epub 2018 Aug 15.
2018
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Cusato J; Pappaccogli M; Berra E; Burrello J; Perlo E; Rabbia F; De Nicolò A; Avataneo V; Di Perri G; Veglio F; Avataneo V; De Nicolò A; Rabbia F; Perlo E; Burrello J; Berra E; Pappaccogli M; Cusato J; D'Avolio A; Di Perri G; Veglio F;

2018
ASL Città di Torino

Tempestilli M; Ammassari A; D'Avolio A; Cicalini S; Gallo AL; Fazio S; Antinori A; Pucillo LP;

Role of CYP24A1, VDR and GC gene polymorphisms on deferasirox pharmacokinetics and clinical outcomes. in The pharmacogenomics journal / Pharmacogenomics J. 2018 May 22;18(3):506-515. doi: 10.1038/tpj.2017.43. Epub 2017 Nov 21.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; De Nicolò A; Massano D; Pirro E; Longo F; Arduino A; De Francia S; Cusato J; Allegra S; D'Avolio A; Allegra S; Cusato J; De Francia S; Arduino A; Longo F; Pirro E; Massano D; De Nicolò A; Piga A; D'Avolio A;

Vitamin D pathway gene polymorphisms and hepatocellular carcinoma in chronic hepatitis C-affected patients treated with new drugs. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2018 Mar;81(3):615-620. doi: 10.1007/s00280-018-3520-0. Epub 2018 Jan 22
2018
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Cantù M; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenetics of the anti-HCV drug sofosbuvir: a preliminary study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2018 Jun 1;73(6):1659-1664. doi: 10.1093/jac/dky053.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway gene polymorphisms affecting daclatasvir plasma concentration at 2 weeks and 1 month of therapy. in Pharmacogenomics / Pharmacogenomics. 2018 Jun 1;19(8):701-707. doi: 10.2217/pgs-2018-0009. Epub 2018 May 23.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Pinna SM; Carcieri C; Guido F; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway genetic variants are able to influence sofosbuvir and its main metabolite pharmacokinetics in HCV mono-infected patients. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2018 Jun;60:42-47. doi: 10.1016/j.meegid.2018.02.016. Epub 2018 Feb 13.
2018
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Carcieri C; Guido F; Avataneo V; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenetic of voriconazole antifungal agent in pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2018 Jul 1;19(11):913-925. doi: 10.2217/pgs-2017-0173. Epub 2018 Jun 19.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Perri GD; Avataneo V; Nicolò A; Cusato J; Carcieri C; Francia S; Pirro E; Fatiguso G; Allegra S;

Precision medicine for HIV: where are we? in Pharmacogenomics / Pharmacogenomics. 2018 Jan;19(2):145-165. doi: 10.2217/pgs-2017-0123. Epub 2017 Dec 5.
2018
ASL Città di Torino

D'Avolio A; Calcagno A; Nicolò A; Allegra S; Cusato J;

Therapeutic drug monitoring of voriconazole for treatment and prophylaxis of invasive fungal infection in children. in British journal of clinical pharmacology / Br J Clin Pharmacol. 2018 Jan;84(1):197-203. doi: 10.1111/bcp.13401. Epub 2017 Sep 24.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Pirro E; Carcieri C; De Francia S; Favata F; Fatiguso G; Allegra S; Allegra S; Fatiguso G; De Francia S; Favata F; Pirro E; Carcieri C; De Nicolò A; Cusato J; Di Perri G; D'Avolio A;

Cannabinoids concentration variability in cannabis olive oil galenic preparations. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2018 Jan;70(1):143-149. doi: 10.1111/jphp.12845. Epub 2017 Oct 23.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

Di Perri G; Canzoneri L; Cusato J; Avataneo V; De Nicolò A; Simiele M; Tomasello C; D'Avolio A; Carcieri C; Carcieri C; Tomasello C; Simiele M; De Nicolò A; Avataneo V; Canzoneri L; Cusato J; Di Perri G; D'Avolio A;

Effect of pharmacogenetic markers of vitamin D pathway on deferasirox pharmacokinetics in children. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2018 Jan;28(1):17-22. doi: 10.1097/FPC.0000000000000315.
2018
ASL Città di Torino

Allegra S; Cusato J; De Francia S; Longo F; Pirro E; Massano D; Piga A; D'Avolio A;

2018
ASL Città di Torino

Motta I; Trunfio M; Calcagno A; Pirriatore V; Scabini S; Palazzo A; Audagnotto S; Fatiguso G; Liberini V; Bellò M; D'Avolio A; Di Perri G; Bonora S;

Clinical relevance of deferasirox trough levels in ?-thalassemia patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2018 Feb;45(2):213-216. doi: 10.1111/1440-1681.12879. Epub 2017 Dec 4.
2018
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Cusato J; Pirro E; Piccione F; Longo F; De Francia S; Massano D; Allegra S; Piga A; Allegra S; Massano D; De Francia S; Longo F; Piccione F; Pirro E; Cusato J; D'Avolio A; Piga A;

Effect of ABCC2 and ABCG2 Gene Polymorphisms and CSF-to-Serum Albumin Ratio on Ceftriaxone Plasma and Cerebrospinal Fluid Concentrations. in Journal of clinical pharmacology / J Clin Pharmacol. 2018 Dec;58(12):1550-1556. doi: 10.1002/jcph.1266. Epub 2018 Jun 6.
2018
ASL Città di Torino

Allegra S; Cardellino CS; Fatiguso G; Cusato J; De Nicolò A; Avataneo V; Bonora S; D'Avolio A; Di Perri G; Calcagno A;

Role of ribavirin in the treatment of hepatitis C virus-associated mixed cryoglobulinemia with interferon-free regimens. in Archives of virology / Arch Virol. 2018 Apr;163(4):961-967. doi: 10.1007/s00705-017-3684-7. Epub 2018 Jan 9.
2018
ASL Città di Torino

Boglione L; Cusato J; Pinna SM; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

2018
ASL Città di Torino

De Nicolò A; Boglione L; Cusato J; Fatiguso G; Favata F; Allegra S; Cariti G; Di Perri G; D'Avolio A;

The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Sep;44(9):965-968. doi: 10.1111/1440-1681.12786.
2017
ASL Città di Torino

El Desoky ES; Abdelhafez AT; Cusato J; Kamel SI; Hussein AM; De Nicolo A; Di Perri G; D'Avolio A;

Role of IL28B genotype in the liver stiffness increase in untreated patients with chronic hepatitis C. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Sep;53:195-198. doi: 10.1016/j.meegid.2017.05.026. Epub 2017 Jun 1.
2017
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

A simple high performance liquid chromatography-mass spectrometry method for Therapeutic Drug Monitoring of isavuconazole and four other antifungal drugs in human plasma samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Oct 25;145:718-724. doi: 10.1016/j.jpba.2017.07.040. Epub 2017 Aug 5.
2017
ASL Città di Torino

Fatiguso G; Favata F; Zedda I; De Nicolò A; Cusato J; Avataneo V; Di Perri G; D'Avolio A;

Reasons to wait or to treat naive patients affected by chronic hepatitis C with low fibrosis stage and genotypes 2 or 3. in European journal of public health / Eur J Public Health. 2017 Oct 1;27(5):938-941. doi: 10.1093/eurpub/ckx025.
2017
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Influence of ABCB11 and HNF4? genes on daclatasvir plasma concentration: preliminary pharmacogenetic data from the Kineti-C study. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Oct 1;72(10):2846-2849. doi: 10.1093/jac/dkx237.
2017
ASL Città di Torino

Cusato J; De Nicolò A; Boglione L; Favata F; Ariaudo A; Mornese Pinna S; Guido F; Avataneo V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Efficacy of sofosbuvir and ledipasvir in an HCV+ gastro-resected patient. in Journal of clinical pharmacy and therapeutics / J Clin Pharm Ther. 2017 Oct;42(5):621-623. doi: 10.1111/jcpt.12546. Epub 2017 May 4.
2017
ASL Città di Torino

Taibi C; Tempestilli M; D'Avolio A; Garbuglia AR; De Nicolò A; Montalbano M; D'Offizi G;

Treatment with direct-acting antiviral agents of hepatitis C virus infection in injecting drug users: A prospective study. in Journal of viral hepatitis / J Viral Hepat. 2017 Oct;24(10):850-857. doi: 10.1111/jvh.12711. Epub 2017 Apr 25.
2017
ASL Città di Torino

Boglione L; Mornese Pinna S; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Evaluation of Posaconazole Pharmacokinetics in Adult Patients with Invasive Fungal Infection. in Biomedicines / Biomedicines. 2017 Nov 20;5(4):66. doi: 10.3390/biomedicines5040066.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; Cusato J; Pirro E; Carcieri C; De Nicolò A; Favata F; De Francia S; Fatiguso G; Allegra S;

Pharmacokinetic evaluation of oral itraconazole for antifungal prophylaxis in children. in Clinical and experimental pharmacology & physiology / Clin Exp Pharmacol Physiol. 2017 Nov;44(11):1083-1088. doi: 10.1111/1440-1681.12822. Epub 2017 Sep 5
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Di Perri G; De Nicolò A; Cusato J; Carcieri C; De Francia S; Favata F; Pirro E; Fatiguso G; Allegra S;

Circannual variation of mitotane and its metabolites plasma levels in patients with adrenocortical carcinoma. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 Nov;69(11):1524-1530. doi: 10.1111/jphp.12798. Epub 2017 Aug 15.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Tampellini M; Di Carlo F; Berruti A; Terzolo M; Daffara FC; Ferrero A; De Martino F; Piccione FM; Pirro E; Carrella S; Allegra S; De Francia S; Cusato J; D'Avolio A;

A rapid and robust UHPLC-DAD method for the quantification of amphotericin B in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 May 10;138:142-145. doi: 10.1016/j.jpba.2017.01.048. Epub 2017 Feb 8.
2017
ASL Città di Torino

Barco S; Zunino A; D'Avolio A; Barbagallo L; Maffia A; Tripodi G; Castagnola E; Cangemi G;

Deferasirox pharmacokinetic evaluation in ?-thalassaemia paediatric patients. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2017 May;69(5):525-528. doi: 10.1111/jphp.12559. Epub 2016 May 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; Pirro E; De Francia S; Cusato J; Allegra S;

Pharmacogenetic analysis of hepatitis C virus related mixed cryoglobulinemia. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):607-611. doi: 10.2217/pgs-2016-0040. Epub 2017 Apr 28.
2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Association of vitamin D pathway SNPs and clinical response to interferon in a cohort of HBeAg-negative patients. in Pharmacogenomics / Pharmacogenomics. 2017 May;18(7):651-661. doi: 10.2217/pgs-2016-0041. Epub 2017 Apr 28.
2017
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Imbornone R; Cardellino CS; Ghisetti V; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Pharmacogenomic influence on sepsis outcome in critically ill patients. in Le infezioni in medicina / Infez Med. 2017 Mar 1;25(1):45-49.
2017
ASL Città di Torino

Allegra S; Fatiguso G; Baietto L; Corcione S; Favata F; Ariaudo A; Pagani N; Ranieri VM; De Rosa FG; Di Perri G; D'Avolio A;

2017
ASL Città di Torino
AOU Città della Salute di Torino

Tandoi F; Romagnoli R; Nonnato A; Calvo PL; Pisciotta C; De Nicolò A; Pinon M; Pensi D; Di Perri G; D'Avolio A;

Pharmacokinetics of linezolid in critically ill patients: impact of continuous venovenous haemofiltration. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2017 Jun;49(6):784-785. doi: 10.1016/j.ijantimicag.2017.04.002. Epub 2017 A
2017
ASL Città di Torino

Corcione S; D'Avolio A; Allegra S; Fanelli V; Urbino R; Ranieri MV; Di Perri G; De Rosa FG;

Role of vitamin D pathway gene polymorphisms on rifampicin plasma and intracellular pharmacokinetics. in Pharmacogenomics / Pharmacogenomics. 2017 Jun;18(9):865-880. doi: 10.2217/pgs-2017-0176. Epub 2017 Jun 8.
2017
ASL Città di Torino

Allegra S; Fatiguso G; Calcagno A; Baietto L; Motta I; Favata F; Cusato J; Bonora S; Di Perri G; D'Avolio A;

Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations. in Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver / Dig Liver Dis. 2017 Jun;49(6):705-708. doi: 10.1016/j.dld.2017.01.144. Epub 2017 Jan 17.
2017
ASL Città di Torino

Boglione L; De Nicolò A; Mornese Pinna S; Cusato J; Favata F; Ariaudo A; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Matrix effect management in liquid chromatography mass spectrometry: the internal standard normalized matrix effect. in Bioanalysis / Bioanalysis. 2017 Jul;9(14):1093-1105. doi: 10.4155/bio-2017-0059. Epub 2017 Jul 24.
2017
ASL Città di Torino

De Nicolò A; Cantù M; D'Avolio A;

Treatment with PEG-IFN and ribavirin in patients with chronic hepatitis C, low grade of hepatic fibrosis, genotype 1 and 4 and favorable IFNL3 genotype: A pharmacogenetic prospective study. in Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases / Infect Genet Evol. 2017 Jul;51:167-172. doi: 10.1016/j.meegid.2017.03.014. Epub 2017 Mar 16.
2017
ASL Città di Torino

Boglione L; Cardellino CS; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Pharmacokinetics of colistin methanesulfonate (CMS) in burn patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2017 Jan;72(1):319-321. doi: 10.1093/jac/dkw361. Epub 2016 Sep 2.
2017
ASL Città di Torino

Corcione S; Baietto L; Malvasio V; Stella M; Di Perri G; D'Avolio A; De Rosa FG;

Efficacy, safety and pharmacokinetics of atazanavir (200mg twice daily) plus raltegravir (400mg twice daily) dual regimen in the clinical setting. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2017 Feb;87:30-36. doi: 10.1016/j.jcv.2016.11.015. Epub 2016 Dec 1.
2017
ASL Città di Torino

Marinaro L; Calcagno A; Ripamonti D; Cenderello G; Pirriatore V; Trentini L; Salassa B; Bramato C; Orofino G; D'Avolio A; Rizzi M; Di Perri G; Rusconi S; Bonora S;

Treatment with daclatasvir and sofosbuvir for 24 weeks without ribavirin in cirrhotic patients who failed first-generation protease inhibitors. in Infection / Infection. 2017 Feb;45(1):103-106. doi: 10.1007/s15010-016-0962-3. Epub 2016 Nov 16.
2017
ASL Città di Torino

Boglione L; Pinna SM; Cardellino CS; De Nicolò A; Cusato J; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

UHPLC-MS/MS method with sample dilution to test therapeutic adherence through quantification of ten antihypertensive drugs in urine samples. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2017 Aug 5;142:279-285. doi: 10.1016/j.jpba.2017.05.018. Epub 2017 May 13.
2017
ASL Città di Torino
AOU Città della Salute di Torino

D'Avolio A; Di Perri G; Veglio F; Mulatero P; Perlo E; Cusato J; Tosello F; Sciandra M; Rabbia F; De Nicolò A; Avataneo V; De Nicolò A; Avataneo V; Rabbia F; Sciandra M; Tosello F; Cusato J; Perlo E; Mulatero P; Veglio F; Di Perri G; D'Avolio A;

Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral Drugs. in Clinical pharmacokinetics / Clin Pharmacokinet. 2017 Apr;56(4):355-369. doi: 10.1007/s40262-016-0456-6.
2017
ASL Città di Torino

Calcagno A; Cusato J; D'Avolio A; Bonora S;

Deferasirox pharmacogenetic influence on pharmacokinetic, efficacy and toxicity in a cohort of pediatric patients. in Pharmacogenomics / Pharmacogenomics. 2017 Apr;18(6):539-554. doi: 10.2217/pgs-2016-0176. Epub 2017 Mar 27.
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Longo F; Massano D; Arduino A; Cusato J; De Francia S; Allegra S; D'Avolio A;

Association of the hOCT1/ABCB1 genotype with efficacy and tolerability of imatinib in patients affected by chronic myeloid leukemia. in Cancer chemotherapy and pharmacology / Cancer Chemother Pharmacol. 2017 Apr;79(4):767-773. doi: 10.1007/s00280-017-3271-3. Epub 2017 Mar 13
2017
ASL Città di Torino
AOU San Luigi di Orbassano

Petrini M; Danesi R; Arrigoni E; Grassi S; Ciabatti E; Fontanelli G; Guerrini F; Cervetti G; D'Avolio A; Fava C; Baratè C; Di Paolo A; Polillo M; Laurino M; Domingo D; Galeotti L; Ceccherini F; Cornolti F; Saglio G; Galimberti S;

Development and validation of UHPLC-MS/MS methods for the quantification of colistin in plasma and dried plasma spots. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Sep 10;129:551-557. doi: 10.1016/j.jpba.2016.08.002. Epub 2016 Aug 2.
2016
ASL Città di Torino

Cangemi G; Barco S; Castagnola E; Tripodi G; Favata F; D'Avolio A;

UHPLC-MS/MS method with protein precipitation extraction for the simultaneous quantification of ten antihypertensive drugs in human plasma from resistant hypertensive patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Sep 10;129:535-541. doi: 10.1016/j.jpba.2016.07.049. Epub 2016 Aug 1.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Di Perri G; Veglio F; Mulatero P; Perlo E; Tomasello C; Cusato J; Bonifacio G; Rabbia F; Avataneo V; De Nicolò A; D'Avolio A;

Deferasirox AUC efficacy cutoff and role of pharmacogenetics. in European journal of clinical pharmacology / Eur J Clin Pharmacol. 2016 Sep;72(9):1155-7. doi: 10.1007/s00228-016-2070-9. Epub 2016 May 18.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Massano D; Piga A; De Francia S; Cusato J; Allegra S;

Effective treatment of hepatitis C virus infection with sofosbuvir and daclatasvir 90?mg in a patient with severe epilepsy on oxcarbazepine. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Sep;48(3):347-8. doi: 10.1016/j.ijantimicag.2016.07.002. Epub 2016 Aug
2016
ASL Città di Torino

Smolders EJ; de Kanter CT; van 't Veer N; D'avolio A; Di Perri G; Burger DM; van Wijngaarden P;

Entecavir plasma concentrations are inversely related to HBV-DNA decrease in a cohort of treatment-naïve patients with chronic hepatitis B. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Sep;48(3):324-7. doi: 10.1016/j.ijantimicag.2016.05.016. Epub 2016 Jul
2016
ASL Città di Torino

Boglione L; De Nicolò A; Cusato J; Bonifacio G; Cariti G; Di Perri G; D'Avolio A;

Deferasirox pharmacokinetic and toxicity correlation in ?-thalassaemia major treatment. in The Journal of pharmacy and pharmacology / J Pharm Pharmacol. 2016 Nov;68(11):1417-1421. doi: 10.1111/jphp.12638. Epub 2016 Sep 27.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Massano D; Pirro E; Cusato J; De Francia S; Allegra S; D'Avolio A;

Sequential therapy with entecavir and peginterferon alpha in chronic hepatitis B: for many but not for all? in Journal of viral hepatitis / J Viral Hepat. 2016 May;23(5):402-3. doi: 10.1111/jvh.12502. Epub 2016 Feb 3.
2016
ASL Città di Torino

Boglione L; Cariti G; Di Perri G; D'Avolio A;

Antihypertensive Bridge Therapy by Continuous Drug Infusion With an Elastomeric Pump in Device-Resistant Hypertension. in Hypertension (Dallas, Tex. : 1979) / Hypertension. 2016 Mar;67(3):e3-4. doi: 10.1161/HYPERTENSIONAHA.115.06978. Epub 2016 Jan 18.
2016
ASL Città di Torino
AOU Città della Salute di Torino

Veglio F; Taddei S; Mulatero P; Bruno RM; Berra E; De Nicolò A; Fulcheri C; Bernini G; D'Avolio A; Rabbia F;

A UHPLC-MS/MS method for the quantification of direct antiviral agents simeprevir, daclatasvir, ledipasvir, sofosbuvir/GS-331007, dasabuvir, ombitasvir and paritaprevir, together with ritonavir, in human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jun 5;125:369-75. doi: 10.1016/j.jpba.2016.04.031. Epub 2016 Apr 20.
2016
ASL Città di Torino

Ariaudo A; Favata F; De Nicolò A; Simiele M; Paglietti L; Boglione L; Cardellino CS; Carcieri C; Di Perri G; D'Avolio A;

Sixty milligram daclatasvir is the right dose for hepatitis C virus treatment in combination with etravirine and darunavir/ritonavir. in AIDS (London, England) / AIDS. 2016 Jun 1;30(9):1491-3. doi: 10.1097/QAD.0000000000001089.
2016
ASL Città di Torino

Smolders EJ; Kanter CT; Grintjes K; D'Avolio A; Di Perri G; van Crevel R; Drenth JP; Burger DM;

Pharmacogenetics of ribavirin-induced anemia in HCV patients. in Pharmacogenomics / Pharmacogenomics. 2016 Jun;17(8):925-41. doi: 10.2217/pgs.16.22. Epub 2016 Jun 1.
2016
ASL Città di Torino

D'Avolio A; Cusato J; De Nicolò A; Allegra S; Di Perri G;

Vitamin D pathway gene polymorphisms as predictors of hepatitis C virus-related mixed cryoglobulinemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2016 Jun;26(6):307-10. doi: 10.1097/FPC.0000000000000223.
2016
ASL Città di Torino

Cusato J; Boglione L; De Nicolò A; Cardellino CS; Carcieri C; Cariti G; Di Perri G; D'Avolio A;

Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump. in International journal of pharmaceutical compounding / Int J Pharm Compd. 2016 Jul-Aug;20(4):343-346.
2016
ASL Città di Torino
AOU Città della Salute di Torino

De Perri G; De Nicolò A; Fulcheri C; Baietto L; Rabbia F; Veglio F; Leggieri A; D'Avolio A; Tomasello C;

Darunavir-based Antiretroviral Therapy may Affect the Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in HCV/HIV-1 Coinfected Patients. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2016 Jul 15;63(2):285-6. doi: 10.1093/cid/ciw292. Epub 2016 May 3.
2016
ASL Città di Torino

Sollima S; D'Avolio A; Cattaneo D; Micheli V; Milazzo L; Gervasoni C;

Ethambutol plasma and intracellular pharmacokinetics: A pharmacogenetic study. in International journal of pharmaceutics / Int J Pharm. 2016 Jan 30;497(1-2):287-92. doi: 10.1016/j.ijpharm.2015.11.044. Epub 2015 Nov 28.
2016
ASL Città di Torino

Bonora S; Perri GD; Cusato J; Favata F; Motta I; Baietto L; Calcagno A; Allegra S; Fatiguso G; D'Avolio A;

UHPLC-MS/MS method with automated on-line solid phase extraction for the quantification of entecavir in peripheral blood mononuclear cells of HBV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2016 Jan 25;118:64-69. doi: 10.1016/j.jpba.2015.10.017. Epub 2015 Oct 22.
2016
ASL Città di Torino

Di Perri G; Tomasello C; Pensi D; Cusato J; Boglione L; Bonifacio G; De Nicolò A; D'Avolio A; De Nicolò A; Bonifacio G; Boglione L; Cusato J; Pensi D; Tomasello C; Di Perri G; D'Avolio A;

Efavirenz pharmacogenetics in a cohort of Italian patients. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2016 Feb;47(2):117-23. doi: 10.1016/j.ijantimicag.2015.11.012. Epub 2015 De
2016
ASL Città di Torino

Di Perri G; Leggieri A; Allegra S; Marinaro L; Bonora S; Calcagno A; Simiele M; Tomasello C; Cusato J; D'Avolio A; Cusato J; Tomasello C; Simiele M; Calcagno A; Bonora S; Marinaro L; Leggieri A; Allegra S; Di Perri G; D'Avolio A;

Deferasirox pharmacokinetics evaluation in a woman with hereditary haemochromatosis and heterozygous ?-thalassaemia. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2016 Dec;84:1510-1512. doi: 10.1016/j.biopha.2016.11.041. Epub 2016 Nov 20.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

Piga A; Pirro E; Arduino A; Cusato J; Massano D; Longo F; De Francia S; Allegra S; D'Avolio A;

Role of HBsAg decline in patients with chronic hepatitis B HBeAg-negative and E genotype treated with pegylated-interferon. in Antiviral research / Antiviral Res. 2016 Dec;136:32-36. doi: 10.1016/j.antiviral.2016.10.011. Epub 2016 Oct 26.
2016
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Daptomycin Pharmacokinetics and Pharmacodynamics in Septic and Critically Ill Patients. in Drugs / Drugs. 2016 Aug;76(12):1161-74. doi: 10.1007/s40265-016-0610-3.
2016
ASL Città di Torino

D'Avolio A; Pensi D; Baietto L; Pacini G; Di Perri G; De Rosa FG;

Role of pharmacogenetics on deferasirox AUC and efficacy. in Pharmacogenomics / Pharmacogenomics. 2016 Apr;17(6):561-72. doi: 10.2217/pgs-2015-0001. Epub 2016 Apr 4.
2016
ASL Città di Torino
AOU San Luigi di Orbassano

D'Avolio A; Piga A; Massano D; De Francia S; Allegra S; Cusato J;

The Role of IL28B Genotype in HCV-RNA Baseline Levels. in Intervirology / Intervirology. 2016;59(2):67-68. doi: 10.1159/000448332. Epub 2016 Sep 8.
2016
ASL Città di Torino

Boglione L; Cusato J; Di Perri G; D'Avolio A;

A Possible Role of Therapeutic Drug Monitoring in Virological Breakthrough during Simeprevir and PEG-IFN Treatment in HCV-4. in Intervirology / Intervirology. 2016;59(5-6):283-284. doi: 10.1159/000477809. Epub 2017 Jun 22.
2016
ASL Città di Torino

Boglione L; Ruggiero T; De Nicolò A; D'Avolio A; Di Perri G;

Raltegravir Plus Nevirapine as Maintenance Antiretroviral Therapy in HIV-Positive Patients: Safety, Efficacy and Pharmacokinetics. in Current HIV research / Curr HIV Res. 2016;14(1):54-60. doi: 10.2174/1570162x13666150929112135.
2016
ASL Città di Torino

Calcagno A; Montrucchio C; Capetti A; Guaraldi G; Cenderello G; Calza L; Lanzafame M; Marinaro L; Tettoni MC; Trentini L; D'Avolio A; Di Perri G; Bonora S;

Development and validation of an ultra performance liquid chromatography tandem mass method for sildenafil and N-desmethyl sildenafil plasma determination and quantification. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2015 Sep 15;1001:35-40. doi: 10.1016/j.jchromb.2015.0
2015
ASL Città di Torino
AOU Città della Salute di Torino

Ranieri VM; D'Avolio A; Di Perri G; Rinaldi M; Ivaldi F; Pasero D; Pensi D; Simiele M;

A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Sep;70(9):2572-5. doi: 10.1093/jac/dkv148. Epub 2015 Jun 11.
2015
ASL Città di Torino

Baietto L; Calcagno A; Motta I; Baruffi K; Poretti V; Di Perri G; Bonora S; D'Avolio A;

A LC-MS method to quantify tenofovir urinary concentrations in treated patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:8-11. doi: 10.1016/j.jpba.2015.05.001. Epub 2015 May 8.
2015
ASL Città di Torino

Simiele M; Carcieri C; De Nicolò A; Ariaudo A; Sciandra M; Calcagno A; Bonora S; Di Perri G; D'Avolio A;

UPLC-MS/MS method for the simultaneous quantification of anti-HBV nucleos(t)ides analogs: Entecavir, lamivudine, telbivudine and tenofovir in plasma of HBV infected patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Oct 10;114:127-32. doi: 10.1016/j.jpba.2015.05.016. Epub 2015 May 22.
2015
ASL Città di Torino

De Nicolò A; Simiele M; Pensi D; Boglione L; Allegra S; Di Perri G; D'Avolio A;

UPLC-MS/MS method with automated on-line SPE for the isomer-specific quantification of the first-generation anti-HCV protease inhibitors in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Nov 10;115:443-9. doi: 10.1016/j.jpba.2015.08.004. Epub 2015 Aug 4.
2015
ASL Città di Torino

De Nicolò A; Abdi AM; Boglione L; Baiett L; Allegra S; Di Perri G; D'Avolio A;

Pharmacokinetics of high dosage of linezolid in two morbidly obese patients-authors' response. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3169. doi: 10.1093/jac/dkv240. Epub 2015 Aug 5.
2015
ASL Città di Torino

Corcione S; Pagani N; Baietto L; Fanelli V; Urbino R; Ranieri VM; Di Perri G; D'Avolio A; De Rosa FG;

Class-specific relative genetic contribution for key antiretroviral drugs. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Nov;70(11):3074-9. doi: 10.1093/jac/dkv207. Epub 2015 Jul 28.
2015
ASL Città di Torino

Siccardi M; Olagunju A; Simiele M; D'Avolio A; Calcagno A; Di Perri G; Bonora S; Owen A;

Pharmacokinetic interactions between telaprevir and antiretroviral drugs in HIV/HCV-coinfected patients with advanced liver fibrosis and prior HCV non-responders. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 May;45(5):545-9. doi: 10.1016/j.ijantimicag.2014.12.035. Epub 2015 Feb
2015
ASL Città di Torino

Milazzo L; Cattaneo D; Calvi E; Gervasoni C; Mazzali C; Ronzi P; Peri AM; Ridolfo AL; D'Avolio A; Antinori S;

An UPLC-MS/MS method coupled with automated on-line SPE for quantification of tacrolimus in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2015 Mar 25;107:512-7. doi: 10.1016/j.jpba.2015.01.054. Epub 2015 Feb 7.
2015
ASL Città di Torino
AOU Città della Salute di Torino

Di Perri G; Brunati A; Nonnato A; Calvo PL; Pinon M; De Nicolò A; Pensi D; D'Avolio A;

Role of CYP27B1+2838 promoter polymorphism in the treatment of chronic hepatitis B HBeAg negative with PEG-interferon. in Journal of viral hepatitis / J Viral Hepat. 2015 Mar;22(3):318-27. doi: 10.1111/jvh.12288. Epub 2014 Jul 24.
2015
ASL Città di Torino

Boglione L; Cusato J; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Intracellular accumulation of boceprevir according to plasma concentrations and pharmacogenetics. in International journal of antimicrobial agents / Int J Antimicrob Agents. 2015 Jun;45(6):657-61. doi: 10.1016/j.ijantimicag.2015.01.019. Epub 2015 Ma
2015
ASL Città di Torino

Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Abdi AM; Cariti G; Di Perri G; D'Avolio A;

Influence of single-nucleotide polymorphisms on deferasirox C trough levels and effectiveness. in The pharmacogenomics journal / Pharmacogenomics J. 2015 Jun;15(3):263-71. doi: 10.1038/tpj.2014.65. Epub 2014 Oct 28.
2015
ASL Città di Torino

Cusato J; Allegra S; Massano D; De Francia S; Piga A; D'Avolio A;

Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients. in Expert opinion on drug metabolism & toxicology / Expert Opin Drug Metab Toxicol. 2015 Jul;11(7):1167-76. doi: 10.1517/17425255.2015.1056732.
2015
ASL Città di Torino

Calcagno A; D'Avolio A; Bonora S;

Effect of SNPs in human ABCB1 on daptomycin pharmacokinetics in Caucasian patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Jan;70(1):307-8. doi: 10.1093/jac/dku368. Epub 2014 Sep 18.
2015
ASL Città di Torino

Baietto L; D'Avolio A; Cusato J; Pace S; Calcagno A; Motta I; Corcione S; Di Perri G; De Rosa FG;

ABCB11 and ABCB1 gene polymorphisms impact on telaprevir pharmacokinetic at one month of therapy. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:63-9. doi: 10.1016/j.biopha.2014.11.007. Epub 2014 Nov 15.
2015
ASL Città di Torino

Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Cariti G; Ciancio A; Smedile A; Strona S; Troshina G; Rizzetto M; Di Perri G; D'Avolio A;

Role of pharmacogenetic in ribavirin outcome prediction and pharmacokinetics in an Italian cohort of HCV-1 and 4 patients. in Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie / Biomed Pharmacother. 2015 Feb;69:47-55. doi: 10.1016/j.biopha.2014.10.030. Epub 2014 Nov 6.
2015
ASL Città di Torino

Allegra S; Cusato J; De Nicolò A; Boglione L; Gatto A; Cariti G; Di Perri G; D'Avolio A;

Relationship between the early boceprevir-S isomer plasma concentrations and the onset of breakthrough during HCV genotype 1 triple therapy. in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases / Clin Microbiol Infect. 2015 Feb;21(2):205.e1-3. doi: 10.1016/j.cmi.2014.07.009. Epub 2014 Oct 29.
2015
ASL Città di Torino

Boglione L; De Nicolò A; Cardellino CS; Ruggiero T; Ghisetti V; Cariti G; Di Perri G; D'Avolio A;

Pharmacokinetics of high dosage of linezolid in two morbidly obese patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Aug;70(8):2417-8. doi: 10.1093/jac/dkv126. Epub 2015 May 8.
2015
ASL Città di Torino

Corcione S; Pagani N; Baietto L; Fanelli V; Urbino R; Ranieri VM; Di Perri G; D'Avolio A; De Rosa FG;

Role of IL28B genotyping in patients with hepatitis C virus-associated mixed cryoglobulinemia and response to PEG-IFN and ribavirin treatment. in Archives of virology / Arch Virol. 2015 Aug;160(8):2009-17. doi: 10.1007/s00705-015-2482-3. Epub 2015 Jun 10.
2015
ASL Città di Torino

Boglione L; Cusato J; Allegra S; Cariti G; Di Perri G; D'Avolio A;

In Vitro Stabilifighty Evaluation of Different Pharmaceutical Products Containing Meropenem. in Hospital pharmacy / Hosp Pharm. 2015 Apr;50(4):296-303. doi: 10.1310/hpj5004-296. Epub 2015 Apr 8.
2015
ASL Città di Torino

Tomasello C; Leggieri A; Cavalli R; Di Perri G; D'Avolio A;

VDR gene polymorphisms impact on anemia at 2 weeks of anti-HCV therapy: a possible mechanism for early RBV-induced anemia. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2015 Apr;25(4):164-72. doi: 10.1097/FPC.0000000000000123.
2015
ASL Città di Torino

Cusato J; Allegra S; Boglione L; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

SLC29A1 polymorphism and prediction of anaemia severity in patients with chronic hepatitis C receiving triple therapy with telaprevir. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2015 Apr;70(4):1155-60. doi: 10.1093/jac/dku519. Epub 2015 Jan 11.
2015
ASL Città di Torino

Milazzo L; Peri AM; Mazzali C; Magni C; Calvi E; De Nicolò A; Clementi E; Cheli S; D'Avolio A; Antinori S; Falvella FS;

Treatment optimization of naïve HCV-1 patients using IL28B, RVR and fibrosis stage. in Antiviral research / Antiviral Res. 2015 Apr;116:45-7. doi: 10.1016/j.antiviral.2015.01.014. Epub 2015 Feb 7.
2015
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Intracellular and Plasma Trough Concentration and Pharmacogenetics of Telaprevir. in Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques / J Pharm Pharm Sci. 2015;18(2):171-6. doi: 10.18433/j3dk6t.
2015
ASL Città di Torino

Cusato J; Allegra S; De Nicolò A; Boglione L; Fatiguso G; Mohamed Abdi A; Cariti G; Di Perri G; D'Avolio A;

Vitamin D pathway gene variants and HCV-2/3 therapy outcomes. in Antiviral therapy / Antivir Ther. 2015;20(3):335-41. doi: 10.3851/IMP2853. Epub 2014 Oct 3.
2015
ASL Città di Torino

Cusato J; Allegra S; Boglione L; De Nicolò A; Baietto L; Cariti G; Di Perri G; D'Avolio A;

Seminal pharmacokinetics and antiviral efficacy of once-daily maraviroc plus lopinavir/ritonavir in HIV-infected patients. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Sep;69(9):2586-8. doi: 10.1093/jac/dku142. Epub 2014 May 8.
2014
ASL Città di Torino

Calcagno A; Nozza S; Simiele M; Milia MG; Chiappetta S; D'Avolio A; Ghisetti V; Lazzarin A; Di Perri G; Bonora S;

Telaprevir-S isomer enhances ribavirin exposure and the ribavirin-related haemolytic anaemia in a concentration-dependent manner. in Antiviral research / Antiviral Res. 2014 Sep;109:7-14. doi: 10.1016/j.antiviral.2014.06.005. Epub 2014 Jun 20.
2014
ASL Città di Torino

De Nicolò A; Boglione L; Ciancio A; Cusato J; Strona S; Cardellino CS; Abdi AM; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G; D'Avolio A;

UPLC-MS/MS method for quantification of the azathioprine metabolites 6-mercaptoguanosine and 6-methylmercaptopurine riboside in peripheral blood mononuclear cells. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Sep;98:271-8. doi: 10.1016/j.jpba.2014.05.040. Epub 2014 Jun 7.
2014
ASL Città di Torino

De Nicolò A; Agnesod D; Simiele M; Riganò D; Adriani A; Canaparo R; Astegiano M; Rizzetto M; Di Perri G; D'Avolio A;

Intracellular accumulation of atazanavir/ritonavir according to plasma concentrations and OATP1B1, ABCB1 and PXR genetic polymorphisms. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Nov;69(11):3061-6. doi: 10.1093/jac/dku234. Epub 2014 Jul 4.
2014
ASL Città di Torino

D'Avolio A; Carcieri C; Cusato J; Simiele M; Calcagno A; Allegra S; Sciandra M; Trentini L; Di Perri G; Bonora S;

Different HBsAg decline after 3 years of therapy with entecavir in patients affected by chronic hepatitis B HBeAg-negative and genotype A, D and E. in Journal of medical virology / J Med Virol. 2014 Nov;86(11):1845-50. doi: 10.1002/jmv.24038. Epub 2014 Aug 8.
2014
ASL Città di Torino

Boglione L; Cardellino CS; De Nicolò A; Cariti G; Di Perri G; D'Avolio A;

Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Mar;90:119-26. doi: 10.1016/j.jpba.2013.11.027. Epub 2013 Dec 1.
2014
ASL Città di Torino

Agnesod D; De Nicolò A; Simiele M; Mohamed Abdi A; Boglione L; Di Perri G; D'Avolio A;

Anidulafungin versus fluconazole: clinical focus on IDSA and ESCMID guidelines. in Le infezioni in medicina / Infez Med. 2014 Jun;22(2):107-11.
2014
ASL Città di Torino

De Rosa FG; Motta I; Corcione S; Cattel F; Di Perri G; D'Avolio A;

A validated HPLC-MS method for quantification of the CCR5 inhibitor maraviroc in HIV+ human plasma. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jun;94:65-70. doi: 10.1016/j.jpba.2014.01.031. Epub 2014 Jan 31.
2014
ASL Città di Torino

Simiele M; Baietto L; Audino A; Sciandra M; Bonora S; Di Perri G; D'Avolio A;

Identification of naïve HVC-4 patients who may be treated with pegylated-interferon and ribavirin according to IL28B polymorphisms. in Antiviral research / Antiviral Res. 2014 Jun;106:105-10. doi: 10.1016/j.antiviral.2014.03.016. Epub 2014 Apr 12.
2014
ASL Città di Torino

Boglione L; Cusato J; De Nicolò A; Cariti G; Allegra S; Ghisetti V; Di Perri G; D'Avolio A;

Triple or dual therapy for HCV-1 naive patients? Optimizing selection tools. in Journal of hepatology / J Hepatol. 2014 Jul;61(1):178-9. doi: 10.1016/j.jhep.2014.02.035. Epub 2014 Mar 21.
2014
ASL Città di Torino

Boglione L; De Nicolò A; Di Perri G; D'Avolio A;

Low-density lipoprotein and ritonavir: an interaction between antiretrovirals and lipids mediated by P-glycoprotein. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2014 Jul;69(7):1760-6. doi: 10.1093/jac/dku066. Epub 2014 Mar 19.
2014
ASL Città di Torino

Tempestilli M; Elisei F; Cimini E; D'Avolio A; Grassi G; Nicastri E; Narciso P; Martini F; Alonzi T; Paolo Pucillo L;

Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimens. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2014 Jul;58(7):4042-7. doi: 10.1128/AAC.00104-14. Epub 2014 May 5.
2014
ASL Città di Torino

De Nicolò A; Simiele M; Calcagno A; Abdi AM; Bonora S; Di Perri G; D'Avolio A;

Voriconazole and atazanavir: a CYP2C19-dependent manageable drug-drug interaction. in Pharmacogenomics / Pharmacogenomics. 2014 Jul;15(10):1281-6. doi: 10.2217/pgs.14.92.
2014
ASL Città di Torino

Calcagno A; Baietto L; Pagani N; Simiele M; Audagnotto S; D'Avolio A; De Rosa FG; Di Perri G; Bonora S;

The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon. in The Journal of infection / J Infect. 2014 Jul;69(1):81-7. doi: 10.1016/j.jinf.2014.02.018. Epub 2014 Mar 14.
2014
ASL Città di Torino

Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A;

Development and validation of an UPLC-PDA method to quantify daptomycin in human plasma and in dried plasma spots. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Jan;88:66-70. doi: 10.1016/j.jpba.2013.08.022. Epub 2013 Aug 28.
2014
ASL Città di Torino

Baietto L; D'Avolio A; Pace S; Simiele M; Marra C; Ariaudo A; Di Perri G; De Rosa FG;

How effective is [corrected] the use of DBS and DPS as tools to encourage widespread therapeutic drug monitoring? in Bioanalysis / Bioanalysis. 2014 Feb;6(4):425-7. doi: 10.4155/bio.13.345.
2014
ASL Città di Torino

Baietto L; Simiele M; D'Avolio A;

Role of IL28-B polymorphisms in the treatment of chronic hepatitis B HBeAg-negative patients with peginterferon. in Antiviral research / Antiviral Res. 2014 Feb;102:35-43. doi: 10.1016/j.antiviral.2013.11.014. Epub 2013 Dec 4.
2014
ASL Città di Torino

Boglione L; Cusato J; Allegra S; Esposito I; Patti F; Cariti G; Di Perri G; D'Avolio A;

Therapeutic drug monitoring of intracellular anti-infective agents. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2014 Dec;101:183-93. doi: 10.1016/j.jpba.2014.03.040. Epub 2014 Apr 3.
2014
ASL Città di Torino

D'Avolio A; Pensi D; Baietto L; Di Perri G;

Etravirine plasma exposure is associated with virological efficacy in treatment-experienced HIV-positive patients. in Antiviral research / Antiviral Res. 2014 Aug;108:44-7. doi: 10.1016/j.antiviral.2014.05.009. Epub 2014 May 23.
2014
ASL Città di Torino

Calcagno A; Marinaro L; Nozza S; Aldieri C; Carbone A; Ghisetti V; Trentalange A; D'Avolio A; Castagna A; Di Perri G; Bonora S;

Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir. in Journal of viral hepatitis / J Viral Hepat. 2014 Apr;21(4):260-3. doi: 10.1111/jvh.12170. Epub 2013 Sep 2.
2014
ASL Città di Torino

Boglione L; De Nicolò A; Cusato J; Cariti G; Di Perri G; D'Avolio A;

A 30-years review on pharmacokinetics of antibiotics: is the right time for pharmacogenetics? in Current drug metabolism / Curr Drug Metab. 2014;15(6):581-98. doi: 10.2174/1389200215666140605130935.
2014
ASL Città di Torino

Baietto L; Corcione S; Pacini G; Perri GD; D'Avolio A; De Rosa FG;

Efficacy, tolerability and virological consequences of long-term use of unboosted atazanavir plus 2 NRTIs in HIV-infected patients. in Current HIV research / Curr HIV Res. 2014;12(5):339-46. doi: 10.2174/1570162x12666140807151616.
2014
ASL Città di Torino

Bonora S; Calcagno A; Vigano O; Bigliano P; Marinaro L; Colella E; Orofino G; Trentini L; Tettoni MC; D'Avolio A; Mercadante S; Galli M; Di Perri G; Rusconi S;

Development and validation of a new UPLC-PDA method to quantify linezolid in plasma and in dried plasma spots. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:42-7. doi: 10.1016/j.jchromb.2013.08.0
2013
ASL Città di Torino

Baietto L; D'Avolio A; Ariaudo A; Corcione S; Simiele M; Cusato J; Urbino R; Di Perri G; Ranieri VM; De Rosa FG;

Association of ITPA polymorphisms rs6051702/rs1127354 instead of rs7270101/rs1127354 as predictor of ribavirin-associated anemia in chronic hepatitis C treated patients. in Antiviral research / Antiviral Res. 2013 Oct;100(1):114-9. doi: 10.1016/j.antiviral.2013.07.021. Epub 2013 Aug 8.
2013
ASL Città di Torino

D'Avolio A; De Nicolò A; Cusato J; Ciancio A; Boglione L; Strona S; Cariti G; Troshina G; Caviglia GP; Smedile A; Rizzetto M; Di Perri G;

A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2013 May 5;78-79:217-23. doi: 10.1016/j.jpba.2013.02.025. Epub 2013 Feb 27.
2013
ASL Città di Torino

D'Avolio A; De Nicolò A; Agnesod D; Simiele M; Mohamed Abdi A; Dilly Penchala S; Boglione L; Cariti G; Di Perri G;

Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2013 Jun;23(6):293-300. doi: 10.1097/FPC.0b013e3283606cb2.
2013
ASL Città di Torino

D'Avolio A; De Francia S; Basile V; Cusato J; De Martino F; Pirro E; Piccione F; Ardito A; Zaggia B; Volante M; Di Perri G; Terzolo M;

Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia. in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology / J Clin Virol. 2013 Feb;56(2):167-9. doi: 10.1016/j.jcv.2012.10.014. Epub 2012 Nov 20.
2013
ASL Città di Torino

Boglione L; D'Avolio A; Cariti G; Di Perri G;

Ultra performance liquid chromatography PDA method for determination of tigecycline in human plasma. in Therapeutic drug monitoring / Ther Drug Monit. 2013 Dec;35(6):853-8. doi: 10.1097/FTD.0b013e31829403b1.
2013
ASL Città di Torino

D'Avolio A; Peila E; Simiele M; Pensi D; Baietto L; Cusato J; Cinnirella G; De Rosa F; Di Perri G;

Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes. in Journal of viral hepatitis / J Viral Hepat. 2013 Apr;20(4):e11-9. doi: 10.1111/jvh.12018. Epub 2013 Feb 18.
2013
ASL Città di Torino

Boglione L; D'Avolio A; Cariti G; Milia MG; Simiele M; De Nicolò A; Ghisetti V; Di Perri G;

Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2013 Apr;68(4):907-10. doi: 10.1093/jac/dks484. Epub 2012 Dec 5.
2013
ASL Città di Torino

D'Avolio A; Simiele M; Calcagno A; Siccardi M; Larovere G; Agati S; Baietto L; Cusato J; Tettoni M; Sciandra M; Trentini L; Di Perri G; Bonora S;

Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D. in Liver international : official journal of the International Association for the Study of the Liver / Liver Int. 2013 Apr;33(4):580-5. doi: 10.1111/liv.12091. Epub 2013 Jan 14.
2013
ASL Città di Torino

Boglione L; D'Avolio A; Cariti G; Gregori G; Burdino E; Baietto L; Cusato J; Ghisetti V; De Rosa FG; Di Perri G;

Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS. in The Journal of antimicrobial chemotherapy / J Antimicrob Chemother. 2012 Nov;67(11):2645-9. doi: 10.1093/jac/dks285. Epub 2012 Aug 7.
2012
ASL Città di Torino

Baietto L; D'Avolio A; Marra C; Simiele M; Cusato J; Pace S; Ariaudo A; De Rosa FG; Di Perri G;

Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Jul;66:376-80. doi: 10.1016/j.jpba.2012.03.030. Epub 2012 Mar 28.
2012
ASL Città di Torino

D'Avolio A; De Nicolò A; Simiele M; Turini S; Agnesod D; Boglione L; Cusato J; Baietto L; Cariti G; Calcagno A; Sciandra M; Di Perri G; Bonora S;

HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC). in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2012 Feb 5;59:109-16. doi: 10.1016/j.jpba.2011.10.003. Epub 2011 Oct 14.
2012
ASL Città di Torino

D'Avolio A; Simiele M; De Francia S; Ariaudo A; Baietto L; Cusato J; Fava C; Saglio G; Di Carlo F; Di Perri G;

2012
ASL Città di Torino

Bonora S; Calcagno A; Cometto C; Fontana S; Aguilar D; D'Avolio A; Gonzalez de Requena D; Maiello A; Dal Conte I; Lucchini A; Di Perri G;

Negative predictive value of IL28B, SLC28A2, and CYP27B1 SNPs and low RBV plasma exposure for therapeutic response to PEG/IFN-RBV treatment. in Therapeutic drug monitoring / Ther Drug Monit. 2012 Dec;34(6):722-8. doi: 10.1097/FTD.0b013e318272e55a.
2012
ASL Città di Torino

D'Avolio A; Ciancio A; Siccardi M; Smedile A; Simiele M; Cusato J; Baietto L; Aguilar Marucco D; Cariti G; Calcagno A; Gonzalez de Requena D; Sciandra M; Troshina G; Caviglia GP; Bonora S; Rizzetto M; Di Perri G;

A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2011 Mar 25;54(4):779-88. doi: 10.1016/j.jpba.2010.10.011. Epub 2010 Nov 10.
2011
ASL Città di Torino

D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Oddone V; Stefani FR; Agati S; Cusato J; Bonora S; Di Perri G;

Ceftriaxone bone penetration in patients with septic non-union of the tibia. in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases / Int J Infect Dis. 2011 Jun;15(6):e415-21. doi: 10.1016/j.ijid.2011.03.003. Epub 2011 Apr 15.
2011
ASL Città di Torino

Garazzino S; Aprato A; Baietto L; D'Avolio A; Maiello A; De Rosa FG; Aloj D; Siccardi M; Biasibetti A; Massè A; Di Perri G;

Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations. in Antimicrobial agents and chemotherapy / Antimicrob Agents Chemother. 2011 Jun;55(6):2976-8. doi: 10.1128/AAC.01236-10. Epub 2011 Mar 14.
2011
ASL Città di Torino

Simiele M; D'Avolio A; Baietto L; Siccardi M; Sciandra M; Agati S; Cusato J; Bonora S; Di Perri G;

2011
ASL Città di Torino

Bonora S; Gonzalez de Requena D; D'Avolio A; Calcagno A; Tettoni M; Siccardi M; Baietto L; Simiele M; Trentini L; Di Perri G;

HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions. in Journal of pharmaceutical and biomedical analysis / J Pharm Biomed Anal. 2010 Sep 5;52(5):774-80. doi: 10.1016/j.jpba.2010.02.026. Epub 2010 Feb 25.
2010
ASL Città di Torino

D'Avolio A; Simiele M; Siccardi M; Baietto L; Sciandra M; Bonora S; Di Perri G;

Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma. in Analytical and bioanalytical chemistry / Anal Bioanal Chem. 2010 Jan;396(2):791-8. doi: 10.1007/s00216-009-3263-1. Epub 2009 Nov 9.
2010
ASL Città di Torino

Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Michelazzo M; Ventimiglia G; Siccardi M; Simiele M; Sciandra M; Di Perri G;

A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2010 Feb;32(1):86-92. doi: 10.1097/FTD.0b013e3181cacbd0.
2010
ASL Città di Torino

D'Avolio A; Simiele M; Baietto L; Siccardi M; Sciandra M; Patanella S; Bonora S; Di Perri G;

Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism. in Pharmacogenetics and genomics / Pharmacogenet Genomics. 2010 Dec;20(12):759-65. doi: 10.1097/FPC.0b013e3283402efb.
2010
ASL Città di Torino

Siccardi M; D'Avolio A; Nozza S; Simiele M; Baietto L; Stefani FR; Moss D; Kwan WS; Castagna A; Lazzarin A; Calcagno A; Bonora S; Back D; Di Perri G; Owen A;

2010
ASL Città di Torino

Baietto L; D'Avolio A; Ventimiglia G; De Rosa FG; Siccardi M; Simiele M; Sciandra M; Di Perri G;

Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV. in Therapeutic drug monitoring / Ther Drug Monit. 2009 Feb;31(1):104-9. doi: 10.1097/FTD.0b013e31819476fa.
2009
ASL Città di Torino

Baietto L; D'Avolio A; De Rosa FG; Garazzino S; Patanella S; Siccardi M; Sciandra M; Di Perri G;

Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America / Clin Infect Dis. 2008 Nov 1;47(9):1222-5. doi: 10.1086/592304.
2008
ASL Città di Torino

Siccardi M; D'Avolio A; Baietto L; Gibbons S; Sciandra M; Colucci D; Bonora S; Khoo S; Back DJ; Di Perri G; Owen A;

A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients. in Journal of chromatographic science / J Chromatogr Sci. 2008 Jul;46(6):524-8. doi: 10.1093/chromsci/46.6.524.
2008
ASL Città di Torino

D'Avolio A; Sciandra M; Siccardi M; Baietto L; Gonzalez de Requena D; Bonora S; Di Perri G;

A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting. in Therapeutic drug monitoring / Ther Drug Monit. 2008 Feb;30(1):90-4. doi: 10.1097/FTD.0b013e31815f4f7e.
2008
ASL Città di Torino

D'Avolio A; Baietto L; De Rosa FG; Garazzino S; Sciandra M; Siccardi M; Bonora S; Di Perri G;

2008
ASL Città di Torino

D'Avolio A; Baietto L; Siccardi M; Sciandra M; Simiele M; Oddone V; Bonora S; Di Perri G;

HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Nov 15;859(2):234-40. doi: 10.1016/j.jchromb.200
2007
ASL Città di Torino

D'Avolio A; Siccardi M; Sciandra M; Baietto L; Bonora S; Trentini L; Di Perri G;

A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Apr 1;848(2):374-8. doi: 10.1016/j.jchromb.2006.
2007
ASL Città di Torino

D'Avolio A; Sciandra M; Siccardi M; Baietto L; de Requena DG; Bonora S; Di Perri G;

Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients. in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences / J Chromatogr B Analyt Technol Biomed Life Sci. 2006 May 1;835(1-2):127-30. doi: 10.1016/j.jchromb.20
2006
ASL Città di Torino

D'Avolio A; Ibañez A; Sciandra M; Siccardi M; de Requena DG; Bonora S; Di Perri G;

An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients. in Therapeutic drug monitoring / Ther Drug Monit. 2006 Feb;28(1):110-5. doi: 10.1097/01.ftd.0000179421.25337.62.
2006
ASL Città di Torino

D'Avolio A; Sciandra M; de Requena DG; Ibañez A; Bonora S; Di Perri G;